A recent study published by researchers at Baylor College of Medicine and Texas Children’s Hospital, in collaboration with the German Center for Infection Research, identified two main subtypes or ...

Tuberculosis is the infectious disease with the highest death rate worldwide. As reported by WHO, therapy-resistant tuberculosis infections are increasing. Diseases due to this bacterial infection may ...

A new experimental vaccine takes aim at one of tuberculosis’s most stubborn defenses: the ability of bacteria to persist despite treatment.

Researchers compare the impacts of cART by itself versus cART plus the IDO inhibitor in lung tissue of nonhuman primates with both TB and SIV. Left: Following just cART, significantly more IDO is ...

Researchers from the faculty of medicine at the University of Ottawa and their international collaborators say they have shown proof-of-concept for a new therapeutic approach in treating tuberculosis ...

Antibiotics transform TB care, but without stable health systems, housing improvements, and poverty reduction, the disease ...

A 76-year-old man on cancer immunotherapy developed a mixed Mycobacterium tuberculosis and Aspergillus fumigatus empyema with pneumothorax, exposing key diagnostic and therapeutic gaps.

In managing the complication of tuberculosis (TB), the phenomenon of a paradoxical reaction must be considered when there are ...

Researchers at São Paulo State University have developed an iron-based compound, loaded into lipid nanoparticles, that completely eliminated tuberculosis bacteria from the lungs of infected mice after ...

A therapy showing promise to help control tuberculosis does not interfere with combined antiretroviral therapy (cART), according to new research. A therapy showing promise to help control tuberculosis ...